WATCH TV LIVE

Tags: pfizer covid vaccine sales

Pfizer Raises Estimates for COVID Vax Sales by $2B

(AP)

Tuesday, 01 November 2022 07:09 AM EDT

Pfizer Inc. on Tuesday raised its full-year estimates for sales of its COVID-19 vaccine by $2 billion to $34 billion, encouraged by demand for its new bivalent booster shots.

The company maintained its full-year sales forecast for COVID-19 pill Paxlovid at $22 billion.

Pfizer and Moderna have rolled out an Omicron-tailored booster dose in Europe and the United States.

It reported third-quarter sales of $22.60 billion, beating the average analyst estimate of $21.04 billion, according to IBES data from Refinitiv.

Click Here to comment on this article

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

Yes, Send Me News Alerts via email

(Optional for Local News)

Privacy: We never share your email address.

Join the Newsmax Community

Read and Post Comments
Please review Community Guidelines before posting a comment.

TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.